Roivant Sciences Ltd. · NASDAQ:ROIV

Venker Eric sold 200,000 Roivant Sciences Ltd. shares (Form 4)

Traded Oct 20, 2026 · Filed Oct 22, 2026

On Oct 20, 2026, Venker Eric (President & Immunovant CEO) sold 200,000 Roivant Sciences Ltd. shares at an average US$35.11 for US$7.02M under a trading plan, leaving 1,399,154 shares. Filed Oct 22, 2026 (Form 4).

Sold: 200,000 shares
Price: US$35.11 average (US$35.09 to US$35.42)
Value: US$7.02M
Holding after: 1,399,154 shares
Trading plan: Yes (Made under a plan set in advance)
Role: President & Immunovant CEO

The filing in full

Date	Security	Transaction	Shares	Price	Holding after	Ownership
Oct 20, 2026	Common Shares	Sale	185,856	US$35.09	1,413,298	Direct
Oct 20, 2026	Common Shares	Sale	14,144	US$35.42	1,399,154	Direct

Source

Download original · View original at SEC

Related